Company

Sysmex Corp

Headquarters: Kobe, Japan

Employees: 8,445

CEO: Mr. Hisashi Ietsugu

JPX: 6869 +0.55%

Market Cap

¥1.576 Trillion

JPY as of July 1, 2024

US$9.76 Billion

Market Cap History

Sysmex Corp market capitalization over time

Evolution of Sysmex Corp market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Sysmex Corp

Detailed Description

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Top 1-year algo backtest: +227.67%

$10,000 in September 2023 would now be $32,767 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Sysmex Corp has the following listings and related stock indices.


Stock: JPX: 6869 wb_incandescent

Stock: FSX: 0YX wb_incandescent

Stock: FSX: 0YX0 wb_incandescent

Stock: OTC: SSMXF wb_incandescent

Stock: OTC: SSMXY wb_incandescent

Details

Headquarters:

1-5-1, Wakinohama-Kaigandori

Chuo-ku

Kobe, 651-0073

Japan

Phone: 81 78 265 0500

Fax: 81 78 265 0524